Hinge Health (HNGE) Draws Fresh Valuation Focus, Is It Fully Priced?

Hinge Health (HNGE) is drawing fresh attention after recent share moves left the digital musculoskeletal care specialist valued at about US$7.9b, with the stock last closing near US$97.86.

Recent trading has been choppy rather than euphoric, with Hinge Health’s share price return down 0.5% on the day but still up 5.9% over 30 days and 114.8% year to date. The 1 year total shareholder return of 81.9% points to strong momentum that has cooled slightly in the very short term as investors reassess growth expectations and risk.

Scan how Hinge Health compares with other high growth, financially solid peers by reviewing our curated list of 20 high quality undiscovered gems.

After Hinge Health’s sharp run, the share price now sits close to analyst targets while still reflecting a steep discount to some intrinsic estimates. Where does fair value really land within that range?

Most Popular Narrative: 33% Undervalued

On the widely followed narrative, Hinge Health screens as undervalued, with a fair value estimate of $145.04 against the latest close at $97.86.

Hinge Health has quickly distinguished itself as one of the most successful IPOs of 2025, combining rapid revenue growth, widening margins, and a scalable AI-driven care model. The company’s focus on musculoskeletal (MSK) health, covering prevention, acute injury, chronic pain, and post-surgical recovery, has resonated with employers and insurers, driving adoption across millions of contracted lives.

See why 1 investors see Hinge Health as 33% undervalued.

Result: Fair Value of $145.04 (UNDERVALUED)

Still, the Hinge Health story can quickly look different if regulatory rules tighten around digital MSK care or if large employer and payer clients pull back.

Find out about the key risks to this Hinge Health narrative.

Another View On Hinge Health’s Valuation

On P/E, Hinge Health tells a very different story. The stock trades on 73.6x earnings, compared with a fair ratio of 36.9x, the US Healthcare industry at 24.6x, and peers at 56.8x. That gap suggests investors are paying up today. How comfortable are you with that premium?

For a deeper look at what those earnings multiples could imply if the market gravitates toward the fair ratio, See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

Plenty in this Hinge Health story looks optimistic on the surface, so move quickly, test the underlying numbers yourself, and weigh the upside signals against the risks in the full breakdown of 3 key rewards

Looking For More Investment Ideas Beyond Hinge Health?

Hinge Health might be front of mind today, but your next strong idea could come from a completely different corner of the market if you widen the search.

• Target robust value by scanning a curated pool of companies that screen as high quality with potential mispricing through the 29 high quality undervalued stocks.
• Strengthen portfolio resilience by focusing on companies with healthier finances through the list of solid balance sheet and fundamentals (25 results).
• Trim portfolio risk by concentrating on businesses that pass tighter stability checks using the 31 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com